Clinical pharmacology of bimatoprost

Expert Opin Drug Metab Toxicol. 2005 Jun;1(1):151-7. doi: 10.1517/17425255.1.1.151.

Abstract

Bimatoprost (Lumigan), Allergan) is a highly efficacious ocular hypotensive agent that provides good diurnal control of intraocular pressure in glaucoma and ocular hypertensive patients. Bimatoprost is a synthetic molecule that is structurally and pharmacologically similar to prostamide F(2), and appears to mimic the activity of the prostamides. Consistent with prostamide-mimetic activity, bimatoprost has potent inherent pharmacological activity in prostamide-sensitive preparations and essentially remains intact in the living primate eye. This is sufficient to explain its potent and efficacious ocular hypotensive activity, and suggests that bimatoprost is a pharmacologically unique compound.

Publication types

  • Review

MeSH terms

  • Amides / chemistry
  • Amides / pharmacokinetics
  • Amides / pharmacology
  • Amides / therapeutic use*
  • Animals
  • Antihypertensive Agents / chemistry
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use*
  • Bimatoprost
  • Cloprostenol / analogs & derivatives
  • Humans
  • Intraocular Pressure / drug effects
  • Intraocular Pressure / physiology
  • Lipids / chemistry
  • Lipids / pharmacokinetics
  • Lipids / pharmacology
  • Lipids / therapeutic use*
  • Ocular Hypertension / drug therapy
  • Ocular Hypertension / epidemiology

Substances

  • Amides
  • Antihypertensive Agents
  • Lipids
  • Cloprostenol
  • Bimatoprost